Behind the Coronavirus Threat, a Middleman Destroying Prescription Drug Markets

Group purchasing organizations (GPOs) have driven many of the generic drug manufacturers out of business, and pushed those remaining to locate factories in China, ground zero for the epidemic.

by

The American Prospect depends on reader support

If you are scraping by right now, please don’t give us anything. But if you have the ability to support independent, non-profit journalism, we are so grateful. Your voluntary contribution helps keep this website paywall-free. You can sign up as a subscriber with a range of benefits, including an opt-in to receive the print magazine by mail.

Click to View Subscriber Levels: IDEAS, POLITICS & POWER